AwesomeCapital
Friday, September 27, 2019
Concert Pharmaceuticals (CNCE) PT Lowered to $18 at Mizuho
Mizuho Securities analyst Didei Yang lowered the price target on Concert Pharmaceuticals (NASDAQ: CNCE) to $18.00 (from $29.00)
https://www.streetinsider.com/Analyst+Comments/Concert+Pharmaceuticals+%28CNCE%29+PT+Lowered+to+%2418+at+Mizuho+Securities/15956685.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
‹
›
Home
View web version
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.